Source: Medicines Authority (MT) Revision Year: 2015 Publisher: 1 A Pharma GmbH, Keltenring 1+3, 82041 Oberhaching, Germany
Alexan, Solution for injection 50 mg/ml.
| Pharmaceutical Form |
|---|
|
Solution for injection. The solution is a clear and colourless solution. |
1 ml contains 50.0 mg Cytarabine.
For a full list of excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cytarabine |
Cytarabine (ARA-C) is metabolised in vivo to ARA-CTP phosphorylated compound. This competitively inhibits DNA polymerase and may also inhibit certain acid kinase enzymes. |
| List of Excipients |
|---|
|
Sodium lactate |
500mg/10ml (box of 1 vial)
1000mg/20ml (box of 1 vial)
2000mg/40ml (box of 1 vial)
Not all pack sizes may be marketed.
1 A Pharma GmbH, Keltenring 1+3, 82041 Oberhaching, Germany
MA939/04101
14th May 2012
| Drug | Countries | |
|---|---|---|
| ALEXAN | Austria, Hong Kong, Israel, Malta, Poland, Tunisia, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
